Immunohistochemical Profile of Uterine Leiomyoma With Bizarre Nuclei; Comparison With Conventional Leiomyoma, Smooth Muscle Tumors of Uncertain Malignant Potential and Leiomyosarcoma

Ali Dastranj Tabrizi ¹, Morteza Ghojazadeh ² * , Hanieh Thagizadeh Anvar ¹, Amir Vahedi ¹, Siamak Naji ³, Elmira Mostafidi ¹, Siamak Berenjian ¹

Cited by CrossRef: 5

1- Mishra S, Patkar R, Neelakantan A. Uterine leiomyoma with bizarre nuclei – A series of four cases. JDPO. 2023;8(4):247 [Crossref]

2- Gregová M, Hojný J, Němejcová K, Bártů M, Mára M, Boudová B, Laco J, Krbal L, Tichá I, Dundr P. Leiomyoma with Bizarre Nuclei: a Study of 108 Cases Focusing on Clinicopathological Features, Morphology, and Fumarate Hydratase Alterations. Pathol Oncol Res. 2020;26(3):1527 [Crossref]

3- Rubisz P, Ciebiera M, Hirnle L, Zgliczyńska M, Łoziński T, Dzięgiel P, Kobierzycki C. The Usefulness of Immunohistochemistry in the Differential Diagnosis of Lesions Originating from the Myometrium. IJMS. 2019;20(5):1136 [Crossref]

4- Akbarzadeh-Jahromi M, Todarbary N, Aslani F, Najib F, Zare M, Amirmoezi F. Uterine smooth muscle tumors of uncertain malignant potential: a retrospective evaluation of clinical pathology and immunohistochemistry features. Surg Exp Pathol. 2024;7(1) [Crossref]

5- Laganà A, Vergara D, Favilli A, La Rosa V, Tinelli A, Gerli S, Noventa M, Vitagliano A, Triolo O, Rapisarda A, Vitale S. Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease. Arch Gynecol Obstet. 2017;296(5):855 [Crossref]